MA

Manfred Auer

Scientific Advisor at Celcuity

Dr. Auer is Research Professor of Chemical and Translational Biology of the Scottish Universities Life Sciences Alliance at the University of Edinburgh. In his lab, he links basic research and applied science by developing and running new miniaturized target, compound and technology platforms comprising all steps from design, theoretical and experimental target analysis, high throughput chemical synthesis and screening, to quantitative mechanistic studies of compound action in cells and model organisms. Before moving to academia, Dr. Auer spent 20 years in the pharmaceutical industry, including service as Executive Director of the Innovative Screening Technologies unit within the Novartis Institutes for Biomedical Research.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Celcuity

Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated companion diagnostic (CDx) and therapeutic (Rx) strategy that leverages the CELsignia CDx platform.


Industries

Employees

11-50

Links